Promoter holding
64.27%
OP
Outrageous Pharmaceuticals Private Limited - Due diligence report
A 360° intelligence report on Outrageous Pharmaceuticals Private Limited: trust score, financial health, credit view, compliance, directors,…
Full Due-Diligence Report + Documents
- Unlock all financial figures & 5-year trends
- Full trust, health & credit-risk scores
- Director details, charges & MCA documents
₹700
₹449
Save ₹251
excl. GST
Or from ₹279/report with credits
View credit packages
Company Credits – Starter
- One credit unlocks this full due-diligence report
- Use across any company’s report, anytime
- Credits valid for 12 months
Choose your own credit amount
View credit packages
Outrageous Pharmaceuticals Private Limited — 360° Intelligence Report
Generated from MCA filings & public records82/100
Trust Score
Low Risk
Outrageous Pharmaceuticals Private Limited is assessed as Low Risk with a Trust Score of 82/100. Outrageous Pharmaceuticals Private Limited is an active private limited indian non-government company incorporated in 2016, operating in the Chemicals sector. The company has shown revenue growth across its recent filed years. It reported a loss in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and moderate financial risk profile.
Report generated on 11 Aug 2026 from the latest processed filings. Outrageous Pharmaceuticals Private Limited snapshot & full profile →
Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.
02
Score Card
Higher is safer · rule-based & explainableTrust ScoreLow Risk
82/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
88/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreModerate
70/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreLow Risk
90/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreLow Risk
85/100
Revenue, profit, asset and hiring momentum.
Distress ScoreModerate
65/100
Early-warning signals - higher means fewer warnings.
03
Financial Intelligence Dashboard
Standalone · 2 filed year(s)Unlock the full 5-year financial dashboard with charts and year-wise figures.
Get full accessScores and observations on this page are already computed from the real filings - only the underlying figures are locked.
04
Credit & Compliance Intelligence
Why the scores are what they are
Credit Risk Score: 90/100 Low Risk
- Liabilities ≈ 38% EBITDA - serviceable.
- No open charges - unencumbered balance sheet.
- Moderate gearing (D/E 1.42).
- Working-capital cover adequate.
Charges position: 0 open (-) · 0 satisfied (-).
Compliance Score: 88/100 Low Risk
- Company status is Active as per MCA.
- Balance sheet slightly behind (Mar 2024).
- 1 active GST registration(s).
05
Director Intelligence
Stability score: 95/100| Name | DIN / PAN | Designation | Appointed | Tenure | DIN status |
|---|---|---|---|---|---|
| PRIYANKA VISHAL PARMAJ | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| KOMAL BHUSHAN SHINDE | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| ALAKA AKARAM PATIL | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
- 3 directors on the board.
- No disqualified or deactivated DINs.
- Stable board - no exits in 3 years.
- Average tenure above 5 years.
06
Ownership & Group Intelligence
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
-
Full shareholding pattern, group structure & capital events →
07
Risk Intelligence Center
Growth 85 · Distress 65
Growth signals & trust indicators
Revenue acceleration: +2.1x over 1 year(s).
Latest year revenue grew 24%.
Asset base grew 0.86 - capacity expansion.
Operating for 10+ years.
Active GST registration(s).
Distress signals & risk flags
Losses deepening year-on-year.
Outside liabilities up 61% in a year.
08
Stakeholder Verdicts
Vendor · Banker · InvestorVendor due diligence79/100
Favourable indicators
Suitability as a supplier / customer counterparty.
- Statutory record is clean.
- 2 distress signal(s) - see Risk Center.
- Financial filings available for verification.
Banker assessment84/100
Favourable lending indicators
Indicative lending comfort for banks, NBFCs and trade credit.
- Debt capacity assessed from filed statements.
- No existing security registered - first-charge position available.
- Compliance record supports lending.
Investor view79/100
Positive growth indicators
Growth quality and scalability through an investor lens.
- 3 growth signal(s) detected.
- Margin and return trends computable from filings.
- Management team looks stable.
09
MCA Filings & Events Timeline
Latest 8 events08 Jan 2025
Last AGM held
Annual general meeting
31 Mar 2024
Latest balance sheet
Filed with ROC
24 Mar 2021
Director ceased
NAJ ASIF RAUT
29 Sep 2018
Director ceased
AKASH DEVIDAS MALE
22 Apr 2016
Incorporated
Registered with Roc Pune
Director appointed
PRIYANKA VISHAL PARMAJ (Director)
Director appointed
KOMAL BHUSHAN SHINDE (Director)
Director appointed
ALAKA AKARAM PATIL (Director)
10
Key Observations
Auto-generated from the data aboveRevenue grew 38% over the last 1 financial year(s).
Net profit margin moved from 1.42 to 2.1x.
Debt-to-equity stands at 24% - manageable leverage.
Net worth is positive.
Compliance record is strong - status, filings and flags are clean.
3 active director(s) / partner(s); board looks stable and experienced.
1 active GST registration(s) indicate ongoing business operations.
| Company | CIN | Location |
|---|---|---|
| Antatah Fashion India (Opc) Private Limited | U18202DL2017OPC326288 | New Delhi, Delhi, India |
| Sui Dhaaga Designs (Opc) Private Limited | U18209DL2017OPC314868 | Delhi, Delhi, India |
| Majagaa Beauty Private Limited | U24100MH2019PTC327694 | Thane, Maharashtra, India |
| Fc Health Services Private Limited | U24299DL2019PTC347658 | Delhi, Delhi, India |
| Blue Ash Chemicals Private Limited | U24131GJ2019PTC109320 | Vadodara, Gujarat, India |
| Blessings Creations (Opc) Private Limited | U18209HR2017OPC071289 | Gurugram, Haryana, India |
| Island Healthcare Private Limited | U24233DL2010PTC201502 | New Delhi, Delhi, India |
| Zola India | U18209TN2018PTC122362 | Chennai, Tamil Nadu, India |
12
Who Uses This Report
CA · CS · Banker · Investor · VendorChartered Accountants (CA)
Verify Outrageous Pharmaceuticals Private Limited before audits and certifications: compliance score 88/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.
Company Secretaries (CS)
Track statutory health of Outrageous Pharmaceuticals Private Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.
Bankers & NBFCs
Current banker verdict: Favourable lending indicators. Credit risk score 90/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.
Investors & Analysts
Investor view: Positive growth indicators. Growth score 85/100, margin trends, ownership structure and peer set for Outrageous Pharmaceuticals Private Limited - screening before a deeper diligence.
Vendors & Procurement Teams
Vendor verdict: Favourable indicators. Trust score 82/100, distress signals and MSME payment-delay disclosures - know whether Outrageous Pharmaceuticals Private Limited pays its suppliers before you extend credit terms.
Lawyers & Compliance Teams
Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Outrageous Pharmaceuticals Private Limited - groundwork for KYC, onboarding and disputes.
13
Frequently Asked Questions
Is Outrageous Pharmaceuticals Private Limited an active company?
Outrageous Pharmaceuticals Private Limited has MCA status “Active” with a compliance score of 88/100 (Low Risk).
Is Outrageous Pharmaceuticals Private Limited financially healthy?
Outrageous Pharmaceuticals Private Limited has a Financial Health Score of 70/100 (Moderate) based on its filed financial statements.
Should I do business with Outrageous Pharmaceuticals Private Limited?
Its overall Trust Score is 82/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.
Who controls Outrageous Pharmaceuticals Private Limited?
See the directors and ownership sections above for board and shareholding detail. 3 active director(s) are on record.
Does Outrageous Pharmaceuticals Private Limited have loans or charges against its assets?
No charges are registered against this company - an unencumbered balance sheet.
Is Outrageous Pharmaceuticals Private Limited up to date with its ROC filings?
Balance sheet slightly behind (Mar 2024). Overall compliance score: 88/100 (Low Risk).
Is it risky to lend to Outrageous Pharmaceuticals Private Limited?
Its Credit Risk Score is 90/100 (Low Risk). Banker verdict: Favourable lending indicators.
Disclaimer: This report is generated automatically from MCA filings and public records as available
in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the
underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are
not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice.
Verify from official sources and consult a qualified professional before any business, lending or investment decision.
If you represent this company and believe any information is inaccurate or outdated,
report it here and we will review promptly.
